Codagenix

Codagenix is a clinical-stage biotechnology company developing preventive vaccines and oncolytic virus therapies. It uses software to recode viral genomes, constructing attenuated live vaccines or viruses to prevent viral infections or treat solid tumors. Codagenix's recoded vaccine candidates fully match the antigens of the target virus and induce a robust immune response against all viral antigens. For cancer, our flexible platform enables us to transform viruses into potential oncolytic immuno-oncology therapies. Both programs rely on scalable, low-cost manufacturing.